McElhenny Sheffield Capital Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-27
Closed -$3.5K 549
2022
Q4
$3.5K Buy
+27
New +$3.5K ﹤0.01% 441